Supplement safety · public sources

Nicotinamide riboside and other NAD+ precursors safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

  1. Research Tracker
  2. Supplement safety
  3. Nicotinamide riboside and other NAD+ precursors

What public sources say about the safety of nicotinamide riboside and other NAD+ precursors: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety

NIH does not publish a fact sheet for this supplement. Ask a pharmacist or clinician to check it against any medicines you take.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
43reports naming it in a suspect product
40where the product is named for it alone
2015–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “NICOTINAMIDE RIBOSIDE”, “NIAGEN”, “NMN”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 3 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 40 reports where a product is named for nicotinamide riboside and other NAD+ precursors alone. This split is made from product names and can misfile some products. Most-reported products: Tru Niagen (12); Chromadex Tru Niagen (5); Tru Niagen Age Better (2); Ultra Nmn (2); Persona Nutrition Tru Niagen (2); Tru Niagen Pro Clinical Strength (2).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Hypersensitivity3
Insomnia3
Diarrhoea3
Vomiting3
Blood pressure increased3
Nausea3
Abdominal pain3
Hepatic enzyme increased2
Malaise2
Abdominal tenderness2
Abdominal pain upper2
Atrial fibrillation2

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (27), Other Serious Outcome (13), Visited Emergency Room (9), Hospitalization (5), Visited a Health Care Provider (5), Disability (4), Life Threatening (3), Other Outcome (1).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

25 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map